99-1033. Agency Information Collection Activities; Announcement of OMB Approval; Dissemination of Information on Unapproved/New Uses for Marketed Drugs, Biologics, and Devices

[Federal Register Volume 64, Number 11 (Tuesday, January 19, 1999)]
[Notices]
[Page 2906]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-1033]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 98N-0222]


Agency Information Collection Activities; Announcement of OMB 
Approval; Dissemination of Information on Unapproved/New Uses for 
Marketed Drugs, Biologics, and Devices

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Dissemination of Information on 
Unapproved/New Uses for Marketed Drugs, Biologics, and Devices'' has 
been approved by the Office of Management and Budget (OMB) under the 
Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of 
Information Resources Management (HFA-250), Food and Drug 
Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.

SUPPLEMENTARY INFORMATION: In the Federal Register of November 20, 1998 
(63 FR 64556), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0390. 
The approval expires on May 31, 1999.

    Dated: January 9, 1999.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 99-1033 Filed 1-15-99; 8:45 am]
BILLING CODE 4160-01-F